SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-159833
Filing Date
2022-05-25
Accepted
2022-05-25 17:23:58
Documents
11
Period of Report
2022-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d360099d8k.htm 8-K 174556
2 EX-2.2 d360099dex22.htm EX-2.2 33224
3 EX-3.3 d360099dex33.htm EX-3.3 81704
4 EX-10.1 d360099dex101.htm EX-10.1 76585
5 EX-10.3 d360099dex103.htm EX-10.3 200001
6 EX-10.5 d360099dex105.htm EX-10.5 51815
7 EX-10.12 d360099dex1012.htm EX-10.12 116795
8 EX-10.13 d360099dex1013.htm EX-10.13 116857
9 EX-21.1 d360099dex211.htm EX-21.1 3052
10 EX-99.1 d360099dex991.htm EX-99.1 330932
11 EX-99.2 d360099dex992.htm EX-99.2 211228
  Complete submission text file 0001193125-22-159833.txt   1398316
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 22964220
SIC: 2834 Pharmaceutical Preparations